For eye doctors

Managing midday fogging in scleral lens wearers

What the evidence says about reservoir debris that clouds vision during wear, how to tell it apart from other causes of blur, and which interventions have been tested.

By the Scleral Lens Team · Updated October 2, 2026 · 14 published sources cited

The short answer

Midday fogging is debris accumulating in the post-lens fluid reservoir, and it is common: a quarter to over half of wearers report it, depending on the study. No single lens parameter or care product explains it; the most consistent associations are with signs of ocular surface inflammation, front-surface nonwetting, and dry eye symptoms. Management is stepwise and mostly supported by small studies: treat lid and surface disease, confirm the filling solution, consider a different filling solution, and refit to change tear exchange or landing zone alignment.

Key points

  • Reported prevalence ranges from 25.8% (a practitioner survey of 248 patients) to 58% (a five-site study of 48 habitual wearers).
  • Lens diameter, haptic design, cleaner, disinfection solution, and filling solution were not associated with fogging in the survey; redness or irritation was.
  • Wearers with fogging had OSDI scores in the severe dry eye range in one prospective study.
  • Filling solution, fenestration, and landing zone studies are small, short, or done in healthy eyes.
  • Fogging is a referral back to the fitter, not an emergency. Blur that does not clear with lens removal is a different problem.

What it is and how common it is

Midday fogging is the accumulation of particulate matter in the fluid reservoir between the lens and the ocular surface. The reservoir is clear at application; over hours of wear it clouds, vision blurs, and the patient removes, cleans, refills, and reapplies the lens.[1] The debris varies in appearance between patients, from fine diffuse particulate to yellow or brown droplets and white globules, which suggests more than one cause.[1]

Estimates of how often it happens depend on how it is measured:

  • Practitioner survey (cross-sectional, multicenter): of 248 patients for whom fogging status was reported, 64 (25.8%) self-reported it.[2]
  • Prospective five-site study: 58% of 48 habitual wearers reported fogging.[3]
  • Veteran cohort of 120 patients: 15.8% reported mid-day fogging or bubbles.[13]
  • Retrospective keratoconus series of 157 eyes: reservoir fogging was recorded as a lens-related event in 7.0% of eyes.[14]

The 2021 review summarizes earlier reports at 26% to 46% of wearers, and cautions that much of the literature rests on small pilot studies and case reports.[1]

What fogging is, and isn’t, associated with

The better-designed studies point away from simple lens or product explanations and toward the ocular surface.

  • Lens design and care products: in the survey, fogging was not associated with age, sex, indication, lens diameter, haptic design, daily cleaner use, disinfection solution, or filling solution. Patients with fogging more often reported redness or irritation with wear, and the authors suggested surface inflammation may contribute.[2]
  • Combined lens and solution properties: in a prospective study of 48 habitual wearers, lens material, coatings, diameter, and storage and filling solutions together accounted for 27.7% of the variance in fogging, and none had a significant effect alone. Median OSDI was 37 with fogging and 10 without, corresponding to severe dry eye and normal eyes respectively.[4]
  • Slit lamp findings: in the five-site study, fit characteristics did not differ between eyes with and without fogging. Front-surface nonwetting and diffuse reservoir haze were significantly more common in eyes with fogging.[3]
  • Reservoir depth: in a three-site study, debris-related fogging was not related to fluid reservoir depth, which ranged widely among successful wearers.[5]
  • Tear exchange: in the companion study, tear exchange occurred within 5 minutes in 64% of eyes. Exchange within 10 seconds had 87% specificity and 71% positive predictive value for fogging, but low sensitivity; exchange between 1 and 5 minutes did not predict it.[6]

Whether the debris itself harms the surface is unknown. In an in vitro study, reservoir fluid collected from healthy new wearers after 8 hours could trigger an inflammatory signaling pathway in cultured corneal epithelial cells; a trend with fogging severity was not statistically significant (r = 0.48, P = 0.09).[11]

Lid disease is common in this population. In 49 habitual wearers, upper lid wiper epitheliopathy was present in 43% of eyes and lower in 31%, and meibomian gland obstruction was more frequent in surface disease than in corneal irregularity (39% vs 11% with no expressible meibum).[12]

Examining a patient who reports fogging

The review recommends confirming fogging by seeing particulate in the reservoir, not relying on symptoms alone, because progressive blur can also come from front-surface deposits or, more urgently, corneal edema.[1] A practical sequence at your visit:

  1. Lens on the eye, after several hours of wear. Look for reservoir haze and its character, front-surface wetting and deposits, and edge alignment in all quadrants.
  2. Fluorescein over the settled lens, if you or the fitter want to grade tear exchange. The review suggests that no dye in the reservoir after five minutes implies a tight, sealed fit, while very rapid ingress points to edge lift or movement.[1]
  3. Lens off. Examine the cornea for edema, staining, and infiltrates, and the conjunctiva at the landing zone.
  4. Lids and surface: meibomian glands, lid margin, lid wiper staining, allergy, and papillae.

Management options reported in the literature

None of these has randomized trial support for fogging specifically. They are listed roughly in the order the 2021 review suggests, from least to most disruptive.[1]

Treat surface and lid inflammation. The review identifies treatment of ocular allergy, giant papillary conjunctivitis, and meibomian gland dysfunction as a priority for wearers with fogging, on the hypothesis that inflammation drives much of the debris.[1] This is often where the referring doctor contributes most.

Confirm the filling solution. The review advises regularly checking that patients actually fill with non-preserved solution, since preserved saline or multipurpose solution is sometimes substituted for cost or convenience.[1]

Change the filling solution. In an open-label study of 22 wearers with fogging, a filling solution mimicking tear ionic composition and pH lowered median OSDI from 27.1 to 9.1 over 5 to 9 days. Objectively graded fogging decreased, but not significantly, and the authors note the subjective gains were likely biased by the unmasked design.[7] In a contralateral-eye study of 22 keratoconus patients, a high-viscosity sodium hyaluronate fill did not reduce turbidity or change settling compared with saline over 8 hours, but low-contrast acuity held up better.[8]

Refit to change tear exchange or alignment. The review frames this by what the dye shows: with little tear exchange, loosen the fit (flatter landing zone, larger diameter, or tear exchange channels); with rapid exchange, match the landing zone more closely to the scleral contour, for example with toric or quadrant-specific designs. Reducing excessive central clearance is also listed.[1] Supporting data are early. In 9 healthy participants, a toric landing zone produced more central and peripheral tear exchange than a spherical one over 100 minutes.[10]

Fenestration. In 20 healthy adults wearing the same lens with and without three 1 mm limbal fenestrations for 3 hours, central reservoir debris increased 2 to 4.8 times more with the non-fenestrated lens. The authors call for longer studies in eyes with disease.[9]

Midday removal and refill. This remains the standard workaround described in the review.[1] It is effective but costs wear time and requires the patient to handle the lens away from home.

What to send back to the fitter

A short note helps: when in the day the fogging starts, how often the patient refills, what you saw in the reservoir and on the front surface, the state of the lids and surface, any new topical medications, and any treatment you started. For patients who also have surface disease, see scleral lenses for ocular surface disease. Patients can find practical steps on the midday fogging guide.

Common questions

Is midday fogging caused by a bad fit?

Not as a rule. In a five-site study of 48 habitual wearers, fit characteristics did not differ between eyes with and without fogging, and in a survey of 248 patients no lens design feature was associated with it. Fit can still contribute in individual eyes, for example through uneven edge alignment or a lens that seals tightly, which is why the fitter assesses tear exchange and landing zone alignment.

Should I tell patients to add artificial tears or a viscous drop to the filling solution?

That is a fitter's decision. A 2021 review notes that adding a non-preserved viscous tear to the filling saline is a common clinical recommendation but had not been formally studied for fogging. A later study of 22 keratoconus patients found a high-viscosity hyaluronate fill did not change reservoir turbidity, although low-contrast acuity held up better than with saline over 8 hours.

How do I tell fogging from corneal edema?

Fogging blur clears when the lens is removed, cleaned, refilled, and reapplied, and debris is visible in the reservoir at the slit lamp. Progressive blur during wear can also come from front-surface deposits or, more urgently, corneal edema. Examine the lens on the eye and the cornea after removal; edema needs a prompt call to the fitter, and to the surgeon in a graft.

Is fogging harmful to the cornea?

There is no clinical evidence that it is. An in vitro study found reservoir fluid from healthy wearers could activate an inflammatory pathway in cultured corneal epithelial cells, but the correlation with fogging severity was not statistically significant. It is mainly a vision and wear-time problem.

Keep reading

Scleral lens complications to watch for

Most scleral lens problems are lens-related rather than physiological: broken lenses, deposits, poor wetting, and midday fogging. Physiological complications are less common and include conjunctival changes at the landing zone, corneal edema (higher risk in grafts), hydrops in keratoconus, and, rarely, microbial keratitis. Infection, rejection, and acute hydrops need same-day care; fit-related findings go back to the fitter.

Co-managing scleral lens patients

The fitter manages the lens: fit, surface response, care regimen, and handling. You continue to manage the underlying disease and everything else in the eye. At your visits, examine the cornea and conjunctiva after lens removal, check acuity in the lens, and measure IOP with the lens out. Average IOP measured after removal has not changed in pooled studies, but pressure during wear is harder to measure and remains an open question for glaucoma and at-risk patients.

Scleral lenses for ocular surface disease referrals

Scleral lenses protect the ocular surface by holding a reservoir of non-preserved saline against the cornea and shielding it from lid shear and evaporation. They are a step 3 therapy in TFOS DEWS II, generally used after lubricants, anti-inflammatory therapy, and punctal occlusion, and often alongside them. Outcome data are strongest for exposure, neurotrophic keratopathy, and ocular GVHD, and weaker for dry eye without corneal involvement. Continuation is lower than in irregular cornea, so set expectations.

Limbal and conjunctival findings in scleral lens wearers

A scleral lens bears on the conjunctiva, so some landing zone change is expected: a faint impression ring after removal usually fades within hours. Sectoral or circumferential blanching during wear with rebound hyperemia after removal, edge impingement, quadrant staining, or limbal staining point to a fit problem that the fitter can usually correct with design changes. Imaging studies show measurable conjunctival vascular and thickness changes under the landing zone, of uncertain long-term significance. Limbal compromise in eyes with limbal stem cell deficiency needs closer attention.

Sources

  1. Fogt JS. Midday fogging of scleral contact lenses: current perspectives. Clin Optom (Auckl). 2021;13:209-219. doi:10.2147/OPTO.S284634 pubmed.ncbi.nlm.nih.gov
  2. Schornack MM, Fogt J, Harthan J, et al. Factors associated with patient-reported midday fogging in established scleral lens wearers. Cont Lens Anterior Eye. 2020;43(6):602-608. doi:10.1016/j.clae.2020.03.005 pubmed.ncbi.nlm.nih.gov
  3. Fogt JS, Schornack M, Nau C, Harthan JS, Nau A, Shorter E. Slit lamp findings in scleral lens wearers with and without subjective fogging. Eye Contact Lens. 2025;51(10):439-444. doi:10.1097/ICL.0000000000001204 pubmed.ncbi.nlm.nih.gov
  4. Fogt JS, Nau C, Harthan J, Shorter E, Nau A, Patton K, Schornack M. Lens and solution properties in patients with and without midday fogging. Ophthalmic Physiol Opt. 2024;44(4):769-773. doi:10.1111/opo.13293 pubmed.ncbi.nlm.nih.gov
  5. Fogt JS, Schornack M, Shorter E, Harthan JS, Nau A, Nau C. Fluid reservoir characteristics in established scleral lens wear, part I: evaluation of fluid reservoir depth and midday fogging. Eye Contact Lens. 2026;52(6):217-222. doi:10.1097/ICL.0000000000001272 pubmed.ncbi.nlm.nih.gov
  6. Fogt JS, Shorter E, Harthan JS, Nau C, Nau A, Schornack M. Fluid reservoir characteristics in established scleral lens wear, part II: evaluation of tear exchange and midday fogging. Eye Contact Lens. 2026;52(6):223-226. doi:10.1097/ICL.0000000000001271 pubmed.ncbi.nlm.nih.gov
  7. Fogt JS, Karres M, Barr JT. Changes in symptoms of midday fogging with a novel scleral contact lens filling solution. Optom Vis Sci. 2020;97(9):690-696. doi:10.1097/OPX.0000000000001559 pubmed.ncbi.nlm.nih.gov
  8. Vurgun EB, Ozkan G, Ozkan G, Turhan SA, Toker AE. The effect of scleral lens reservoir solution on post-lens fluid turbidity and settling in patients with keratoconus. Eye Contact Lens. 2025;51(12):529-535. doi:10.1097/ICL.0000000000001231 pubmed.ncbi.nlm.nih.gov
  9. Fisher D, Colorado LH, Alonso-Caneiro D, Vincent SJ. Scleral lens fenestrations and fluid reservoir debris. Ophthalmic Physiol Opt. 2026;46(5):1211-1217. doi:10.1007/s44402-026-00150-z pubmed.ncbi.nlm.nih.gov
  10. Iqbal A, Fisher D, Alonso-Caneiro D, Collins MJ, Vincent SJ. Scleral lens landing zone toricity and tear exchange. Cont Lens Anterior Eye. 2026;49(1):102571. doi:10.1016/j.clae.2025.102571 pubmed.ncbi.nlm.nih.gov
  11. Walker MK, Lema C, Redfern R. Potential pro-inflammatory impact of scleral lens midday fogging on human corneal epithelial cells: an in vitro study. Cont Lens Anterior Eye. 2024;47(5):102187. doi:10.1016/j.clae.2024.102187 pubmed.ncbi.nlm.nih.gov
  12. Harthan JS, Nau A, Shorter E, Nau CB, Schornack M, Fogt JS. Presence of eyelid disease in habitual scleral lens wearers. J Clin Med. 2026;15(9):3181. doi:10.3390/jcm15093181 pubmed.ncbi.nlm.nih.gov
  13. Kanakamedala A, Salazar H, Campagna G, et al. Outcomes of scleral contact lens use in veteran population. Eye Contact Lens. 2020;46(6):348-352. doi:10.1097/ICL.0000000000000671 pubmed.ncbi.nlm.nih.gov
  14. Fuller DG, Wang Y. Safety and efficacy of scleral lenses for keratoconus. Optom Vis Sci. 2020;97(9):741-748. doi:10.1097/OPX.0000000000001578 pubmed.ncbi.nlm.nih.gov

Last updated October 2, 2026. Found an error or a newer study? Let us know and we'll correct the page.